Exclusive - Geopolitical Situation Revives Saudi Foreign Trade

A night view of the Saudi capital Riyadh. (Reuters)
A night view of the Saudi capital Riyadh. (Reuters)
TT

Exclusive - Geopolitical Situation Revives Saudi Foreign Trade

A night view of the Saudi capital Riyadh. (Reuters)
A night view of the Saudi capital Riyadh. (Reuters)

Saudi Arabia's foreign trade will benefit from the geopolitical situation in the region, predicted economic experts.

They told Asharq Al-Awsat that Iran will be the greatest loser from the geopolitical scene given the recently re-imposed US economic sanctions.

Washington’s mounting disputes with a number of powers, including China and the European Union, will also favor the Kingdom.

Economic researcher Dr. Ahmed Jibril told Asharq Al-Awsat that Riyadh will reap the benefits of these developments, especially given its strategic alliance with Washington.

It finds itself in a position to execute a number of joint agreements with the US, he continued.

Saudi Arabia and the US struck during a landmark summit in Riyadh in 2017 deals worth 280 billion dollars.

Jibril predicted that Washington will seek to cement its comprehensive cooperation with Saudi Arabia that will ultimately benefit both countries.

Economist and professor at Jeddah University Dr. Salem Baajaja expected Saudi Arabia to flourish on the trade level, taking advantage of the tensions on the international scene.

The US, European Union, China, South Korea and Russia may eventually realize that they will need to increase their trade with the Kingdom, he told Asharq Al-Awsat.

Foreign trade is a key element in the Kingdom’s economy and it plays a major part in its development, he continued.

He stressed that the US sanctions on Iran will favor Saudi Arabia and its foreign trade, especially in regards to oil.

Saudi oil may represent a substitute to Iran’s when the November 4 US sanctions against Tehran’s oil exports take effect.

Economist Dr. Abdullah al-Maghlouth told Asharq Al-Awsat that Saudi Arabia is in a position to control its own fate in regards to foreign trade given its foreign policies that allow it to take advantage of geopolitical developments.

Many countries, he noted, revealed that they will turn to the Kingdom for their oil when the Iran sanctions kick in.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.